{"id":316820,"date":"2026-10-19T14:31:35","date_gmt":"2026-10-19T09:01:35","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=316820"},"modified":"2026-10-19T14:31:35","modified_gmt":"2026-10-19T09:01:35","slug":"medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/","title":{"rendered":"3 Medical Device, Surface Chemical and Helmet Stocks With a Strong Future Roadmap: Poly Medicure, Grauer &#038; Weil (India) and Studds Accessories"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Poly Medicure Rs 1,593.80, P\/E 51.87. Grauer &amp; Weil Rs 78.83, P\/E 22.12. Studds Rs 407.15, P\/E 21.92. Closing prices of 14 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Medical device, surface chemical and helmet stocks with the clearest long-term roadmaps today include Poly Medicure in medical devices such as infusion sets, needles, catheters and dialysis products sold in India and many export markets, Grauer &amp; Weil in surface treatment chemicals and related industrial products and Studds in motorcycle helmets and riding accessories sold in India and overseas. FY26 revenue growth was 13.4% at Poly Medicure, 5.1% at Grauer &amp; Weil and 8.4% at Studds. P\/E stands at 51.87 for Poly Medicure (industry 62.79), 22.12 for Grauer &amp; Weil (industry 36.60) and 21.92 for Studds (industry 36.50). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company&#8217;s risks need equal attention.<\/p>\n<\/p><\/div>\n<p>Medical device, surface chemical and helmet stocks give investors exposure to hospital supplies, industrial chemicals and safety gear. Volumes, export demand and margins decide how much of that demand turns into profit.<\/p>\n<p>This list covers three medical device, surface chemical and helmet stocks: Poly Medicure for medical devices such as infusion sets, needles, catheters and dialysis products sold in India and many export markets, Grauer &amp; Weil (India) for surface treatment chemicals and related industrial products and Studds Accessories for motorcycle helmets and riding accessories sold in India and overseas. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#What_Are_Medical_Device_Surface_Chemical_and_Helmet_Stocks\" title=\"What Are Medical Device, Surface Chemical and Helmet Stocks?\">What Are Medical Device, Surface Chemical and Helmet Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#Medical_Device_Surface_Chemical_and_Helmet_Stocks_at_a_Glance\" title=\"Medical Device, Surface Chemical and Helmet Stocks at a Glance\">Medical Device, Surface Chemical and Helmet Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#Why_Do_Medical_Device_Surface_Chemical_and_Helmet_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Medical Device, Surface Chemical and Helmet Stocks Have a Strong Roadmap in India?\">Why Do Medical Device, Surface Chemical and Helmet Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#Poly_Medicure_Medical_Devices_Build_the_Next_Leg\" title=\"Poly Medicure: Medical Devices Build the Next Leg\">Poly Medicure: Medical Devices Build the Next Leg<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#Grauer_Weil_India_Surface_Treatment_Chemicals_Drive_the_Pipeline\" title=\"Grauer &amp; Weil (India): Surface Treatment Chemicals Drive the Pipeline\">Grauer &amp; Weil (India): Surface Treatment Chemicals Drive the Pipeline<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#Studds_Accessories_Helmets_and_Riding_Gear_Build_the_Next_Leg\" title=\"Studds Accessories: Helmets and Riding Gear Build the Next Leg\">Studds Accessories: Helmets and Riding Gear Build the Next Leg<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#Best_Medical_Device_Surface_Chemical_and_Helmet_Stocks_in_India_Poly_Medicure_vs_Grauer_Weil_vs_Studds_on_Key_Financials\" title=\"Best Medical Device, Surface Chemical and Helmet Stocks in India: Poly Medicure vs Grauer &amp; Weil vs Studds on Key Financials\">Best Medical Device, Surface Chemical and Helmet Stocks in India: Poly Medicure vs Grauer &amp; Weil vs Studds on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#How_to_Evaluate_Medical_Device_Surface_Chemical_and_Helmet_Stocks_to_Buy_Before_You_Invest\" title=\"How to Evaluate Medical Device, Surface Chemical and Helmet Stocks to Buy Before You Invest\">How to Evaluate Medical Device, Surface Chemical and Helmet Stocks to Buy Before You Invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#Risks_to_Consider_Before_Investing_in_Medical_Device_Surface_Chemical_and_Helmet_Stocks\" title=\"Risks to Consider Before Investing in Medical Device, Surface Chemical and Helmet Stocks\">Risks to Consider Before Investing in Medical Device, Surface Chemical and Helmet Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#Final_Take_Which_Stock_Has_the_Strongest_Roadmap\" title=\"Final Take: Which Stock Has the Strongest Roadmap?\">Final Take: Which Stock Has the Strongest Roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#FAQs_on_Medical_Device_Surface_Chemical_and_Helmet_Stocks\" title=\"FAQs on Medical Device, Surface Chemical and Helmet Stocks\">FAQs on Medical Device, Surface Chemical and Helmet Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#Which_are_the_best_medical_device_surface_chemical_and_helmet_stocks_in_India_with_a_strong_roadmap\" title=\"Which are the best medical device, surface chemical and helmet stocks in India with a strong roadmap?\">Which are the best medical device, surface chemical and helmet stocks in India with a strong roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#Is_Poly_Medicure_a_good_stock_to_buy_now\" title=\"Is Poly Medicure a good stock to buy now?\">Is Poly Medicure a good stock to buy now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#What_is_the_PE_ratio_of_Poly_Medicure_Grauer_Weil_and_Studds\" title=\"What is the P\/E ratio of Poly Medicure, Grauer &amp; Weil and Studds?\">What is the P\/E ratio of Poly Medicure, Grauer &amp; Weil and Studds?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#Which_of_these_medical_device_surface_chemical_and_helmet_stocks_has_the_highest_return_on_equity\" title=\"Which of these medical device, surface chemical and helmet stocks has the highest return on equity?\">Which of these medical device, surface chemical and helmet stocks has the highest return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#What_are_the_risks_of_investing_in_medical_device_surface_chemical_and_helmet_stocks\" title=\"What are the risks of investing in medical device, surface chemical and helmet stocks?\">What are the risks of investing in medical device, surface chemical and helmet stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#How_did_Poly_Medicure_Grauer_Weil_and_Studds_perform_in_Q1_FY27\" title=\"How did Poly Medicure, Grauer &amp; Weil and Studds perform in Q1 FY27?\">How did Poly Medicure, Grauer &amp; Weil and Studds perform in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#Do_medical_device_surface_chemical_and_helmet_stocks_pay_dividends\" title=\"Do medical device, surface chemical and helmet stocks pay dividends?\">Do medical device, surface chemical and helmet stocks pay dividends?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/medical-device-surface-chemical-and-helmet-stocks-roadmap-anchor-list\/#How_can_I_invest_in_medical_device_surface_chemical_and_helmet_stocks_in_India\" title=\"How can I invest in medical device, surface chemical and helmet stocks in India?\">How can I invest in medical device, surface chemical and helmet stocks in India?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Medical_Device_Surface_Chemical_and_Helmet_Stocks\"><\/span><strong>What Are Medical Device, Surface Chemical and Helmet Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Medical device, surface chemical and helmet stocks are shares of companies that make health products, chemicals or run restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Medical_Device_Surface_Chemical_and_Helmet_Stocks_at_a_Glance\"><\/span><strong>Medical Device, Surface Chemical and Helmet Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares size, valuation, return on equity and debt for the three medical device, surface chemical and helmet stocks as of the 14 Oct 2026 close.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Debt to Equity<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/polymed\/poly-medicure-ltd-share-price-today\">Poly Medicure<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,593.80<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16,231<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">51.87<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">62.79<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.37%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/grauweil\/grauer-weil-india-ltd-share-price-today\">Grauer &amp; Weil (India)<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">78.83<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,540<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22.12<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.60<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.16%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.01<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/studds\/studds-accessories-ltd-share-price-today\">Studds Accessories<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">407.15<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,637<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.92<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.50<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.80%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.02<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Among healthcare, chemicals and consumer stocks, all three trade at a discount to their industry P\/E multiples.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Medical_Device_Surface_Chemical_and_Helmet_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Medical Device, Surface Chemical and Helmet Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Medical device, surface chemical and helmet stocks have a strong roadmap in India because hospital device demand, manufacturing output and two-wheeler ownership keep adding volumes for these firms. Three drivers stand out.<\/p>\n<ul>\n<li><strong>Hospital demand:<\/strong> Hospitals buy infusion, catheter and dialysis products.<\/li>\n<li><strong>Manufacturing output:<\/strong> Factories use surface treatment chemicals.<\/li>\n<li><strong>Two-wheeler riders:<\/strong> Safety rules and rising incomes lift helmet demand.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Poly_Medicure_Medical_Devices_Build_the_Next_Leg\"><\/span><strong>Poly Medicure: Medical Devices Build the Next Leg<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Poly Medicure&#8217;s roadmap rests on medical devices such as infusion sets, needles, catheters and dialysis products sold in India and many export markets, with rising healthcare consumption and export demand supporting growth.<\/p>\n<p>Revenue grew from Rs 960.97 crore in FY22 to Rs 1,995.34 crore in FY26, a 107.6% rise, and FY26 revenue was 13.4% higher than FY25. FY26 net profit was Rs 320.73 crore. In Q1 FY27, revenue grew 25.5% to Rs 558.79 crore. Operating margin was 27.65% in FY26.<\/p>\n<p>Debt to equity is 0.11 and return on equity is 10.37%. FY26 operating cash flow was Rs 246.37 crore against capital expenditure of Rs 308.39 crore. Poly Medicure paid a dividend of Rs 3.5 per share for FY26, a yield of 0.22%. At a P\/E of 51.87 against an industry P\/E of 62.79, the stock trades below its industry multiple.<\/p>\n<p>What to watch: The P\/E of 51.87 against an industry P\/E of 62.79 leaves valuation less stretched, so the next quarters&#8217; growth is the figure to follow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Grauer_Weil_India_Surface_Treatment_Chemicals_Drive_the_Pipeline\"><\/span><strong>Grauer &amp; Weil (India): Surface Treatment Chemicals Drive the Pipeline<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Grauer &amp; Weil&#8217;s roadmap rests on surface treatment chemicals and related industrial products, with several business lines supporting earnings.<\/p>\n<p>Revenue grew from Rs 782.11 crore in FY22 to Rs 1,239.78 crore in FY26, a 58.5% rise, and FY26 revenue was 5.1% higher than FY25. FY26 net profit rose 4.3% to Rs 164.03 crore. Over four years, net profit rose from Rs 78.77 crore in FY22 to Rs 164.03 crore. In Q1 FY27, revenue grew 17.0% to Rs 311.11 crore. Operating margin was 18.87% in FY26.<\/p>\n<p>Debt to equity is 0.01 and return on equity is 15.16%. FY26 operating cash flow was Rs 151.86 crore against capital expenditure of Rs 53.65 crore. Grauer &amp; Weil paid a dividend of Rs 1 per share for FY26, a yield of 1.28%. At a P\/E of 22.12 against an industry P\/E of 36.60, the stock trades below its industry multiple.<\/p>\n<p>What to watch: The P\/E of 22.12 against an industry P\/E of 36.60 leaves valuation less stretched, so the next quarters&#8217; growth is the figure to follow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Studds_Accessories_Helmets_and_Riding_Gear_Build_the_Next_Leg\"><\/span><strong>Studds Accessories: Helmets and Riding Gear Build the Next Leg<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Studds&#8217; roadmap rests on motorcycle helmets and riding accessories sold in India and overseas, with rising two-wheeler use and safety awareness supporting volumes.<\/p>\n<p>Revenue grew from Rs 467.98 crore in FY22 to Rs 645.75 crore in FY26, a 38.0% rise, and FY26 revenue was 8.4% higher than FY25. FY26 net profit rose 18.7% to Rs 82.65 crore. Over four years, net profit rose from Rs 28.64 crore in FY22 to Rs 82.65 crore. In Q1 FY27, revenue grew 13.8% to Rs 172.92 crore. Operating margin was 21.25% in FY26.<\/p>\n<p>Debt to equity is 0.02 and return on equity is 15.80%. FY26 operating cash flow was Rs 86.42 crore against capital expenditure of Rs 47.04 crore. Studds paid a dividend of Rs 3 per share for FY26, a yield of 0.72%. At a P\/E of 21.92 against an industry P\/E of 36.50, the stock trades below its industry multiple.<\/p>\n<p>What to watch: The P\/E of 21.92 against an industry P\/E of 36.50 leaves valuation less stretched, so the next quarters&#8217; growth is the figure to follow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Best_Medical_Device_Surface_Chemical_and_Helmet_Stocks_in_India_Poly_Medicure_vs_Grauer_Weil_vs_Studds_on_Key_Financials\"><\/span><strong>Best Medical Device, Surface Chemical and Helmet Stocks in India: Poly Medicure vs Grauer &amp; Weil vs Studds on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the best medical device, surface chemical and helmet stocks in India, Poly Medicure leads on FY26 revenue growth and FY26 operating margin; Grauer &amp; Weil leads on the lowest debt to equity and dividend yield; Studds leads on return on equity and the lowest P\/E. The table puts the numbers side by side.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Metric<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Poly Medicure<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Grauer &amp; Weil<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Studds<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,995.34<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,239.78<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">645.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue growth<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.4%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5.1%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 net profit (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">320.73<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">164.03<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">82.65<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 operating profit margin<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">27.65%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.87%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.25%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Q1 FY27 revenue growth (YoY)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">25.5%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.0%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Return on equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.37%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.16%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.80%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">P\/E ratio<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">51.87<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22.12<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.92<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Debt to equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.11<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.01<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.02<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Dividend yield<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.22%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1.28%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.72%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 operating cash flow (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">246.37<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">151.86<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">86.42<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Healthcare, chemicals and food earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Evaluate_Medical_Device_Surface_Chemical_and_Helmet_Stocks_to_Buy_Before_You_Invest\"><\/span><strong>How to Evaluate Medical Device, Surface Chemical and Helmet Stocks to Buy Before You Invest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A short checklist keeps the research consistent when you screen medical device, surface chemical and helmet stocks and shortlist medical device, surface chemical and helmet stocks to buy.<\/p>\n<ol>\n<li>Compare each stock&#8217;s P\/E with its industry P\/E, which differs by company here.<\/li>\n<li>Check revenue growth, operating margin and cash flow together.<\/li>\n<li>Check whether revenue growth is turning into profit growth, not only sales.<\/li>\n<li>Read operating cash flow against capital expenditure to see how growth is funded.<\/li>\n<li>Watch debt to equity and interest cover before sizing a position.<\/li>\n<li>Spread exposure across companies and business lines instead of one demand cycle.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these medical device, surface chemical and helmet stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Consider_Before_Investing_in_Medical_Device_Surface_Chemical_and_Helmet_Stocks\"><\/span><strong>Risks to Consider Before Investing in Medical Device, Surface Chemical and Helmet Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Consumer demand:<\/strong> Spending patterns can shift sales between quarters.<\/li>\n<li><strong>Input costs:<\/strong> Changes in raw material prices can affect margins.<\/li>\n<li><strong>Quarterly trends:<\/strong> A single weak quarter can change near-term earnings, so track results every quarter.<\/li>\n<\/ul>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Poly Medicure, Grauer &amp; Weil and Studds live.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Take_Which_Stock_Has_the_Strongest_Roadmap\"><\/span><strong>Final Take: Which Stock Has the Strongest Roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>These three healthcare, chemicals and consumer stocks cover medical devices, surface chemicals and helmets. Poly Medicure leads on FY26 revenue growth and FY26 operating margin; Grauer &amp; Weil leads on the lowest debt to equity and dividend yield; Studds leads on return on equity and the lowest P\/E.<\/p>\n<p>Across medical device, surface chemical and helmet stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the medical device, surface chemical and helmet stocks to buy discussed here.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Medical_Device_Surface_Chemical_and_Helmet_Stocks\"><\/span><strong>FAQs on Medical Device, Surface Chemical and Helmet Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_medical_device_surface_chemical_and_helmet_stocks_in_India_with_a_strong_roadmap\"><\/span><strong>Which are the best medical device, surface chemical and helmet stocks in India with a strong roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Poly Medicure, Grauer &amp; Weil (India) and Studds Accessories stand out for their roadmaps in medical devices, surface chemicals and helmets. FY26 revenue growth was 13.4% at Poly Medicure, 5.1% at Grauer &amp; Weil and 8.4% at Studds, and return on equity ranges from 10.37% to 15.80%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Poly_Medicure_a_good_stock_to_buy_now\"><\/span><strong>Is Poly Medicure a good stock to buy now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Poly Medicure has a debt to equity ratio of 0.11, a return on equity of 10.37% and a P\/E of 51.87 against an industry P\/E of 62.79. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_Poly_Medicure_Grauer_Weil_and_Studds\"><\/span><strong>What is the P\/E ratio of Poly Medicure, Grauer &amp; Weil and Studds?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/E ratio is 51.87 for Poly Medicure (industry 62.79), 22.12 for Grauer &amp; Weil (industry 36.60) and 21.92 for Studds (industry 36.50). All of them trade below the industry multiple.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_medical_device_surface_chemical_and_helmet_stocks_has_the_highest_return_on_equity\"><\/span><strong>Which of these medical device, surface chemical and helmet stocks has the highest return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Studds Accessories has the highest return on equity at 15.80%, followed by Grauer &amp; Weil (India) at 15.16% and Poly Medicure at 10.37%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_medical_device_surface_chemical_and_helmet_stocks\"><\/span><strong>What are the risks of investing in medical device, surface chemical and helmet stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Poly_Medicure_Grauer_Weil_and_Studds_perform_in_Q1_FY27\"><\/span><strong>How did Poly Medicure, Grauer &amp; Weil and Studds perform in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Poly Medicure reported revenue of Rs 558.79 crore, up 25.5% year on year. Grauer &amp; Weil (India) reported revenue of Rs 311.11 crore, up 17.0% year on year. Studds Accessories reported revenue of Rs 172.92 crore, up 13.8% year on year.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Do_medical_device_surface_chemical_and_helmet_stocks_pay_dividends\"><\/span><strong>Do medical device, surface chemical and helmet stocks pay dividends?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, all three companies pay dividends. The dividend yield is 0.22% for Poly Medicure, 1.28% for Grauer &amp; Weil and 0.72% for Studds, based on dividends declared for FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_invest_in_medical_device_surface_chemical_and_helmet_stocks_in_India\"><\/span><strong>How can I invest in medical device, surface chemical and helmet stocks in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can buy medical device, surface chemical and helmet stocks through a demat and trading account on NSE or BSE after checking each company&#8217;s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best medical device, surface chemical and helmet stocks in India with a strong roadmap?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Poly Medicure, Grauer & Weil (India) and Studds Accessories stand out for their roadmaps in medical devices, surface chemicals and helmets. FY26 revenue growth was 13.4% at Poly Medicure, 5.1% at Grauer & Weil and 8.4% at Studds, and return on equity ranges from 10.37% to 15.80%.\"}},{\"@type\":\"Question\",\"name\":\"Is Poly Medicure a good stock to buy now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Poly Medicure has a debt to equity ratio of 0.11, a return on equity of 10.37% and a P\/E of 51.87 against an industry P\/E of 62.79. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.\"}},{\"@type\":\"Question\",\"name\":\"What is the P\/E ratio of Poly Medicure, Grauer & Weil and Studds?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The P\/E ratio is 51.87 for Poly Medicure (industry 62.79), 22.12 for Grauer & Weil (industry 36.60) and 21.92 for Studds (industry 36.50). All of them trade below the industry multiple.\"}},{\"@type\":\"Question\",\"name\":\"Which of these medical device, surface chemical and helmet stocks has the highest return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Studds Accessories has the highest return on equity at 15.80%, followed by Grauer & Weil (India) at 15.16% and Poly Medicure at 10.37%.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in medical device, surface chemical and helmet stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.\"}},{\"@type\":\"Question\",\"name\":\"How did Poly Medicure, Grauer & Weil and Studds perform in Q1 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Poly Medicure reported revenue of Rs 558.79 crore, up 25.5% year on year. Grauer & Weil (India) reported revenue of Rs 311.11 crore, up 17.0% year on year. Studds Accessories reported revenue of Rs 172.92 crore, up 13.8% year on year.\"}},{\"@type\":\"Question\",\"name\":\"Do medical device, surface chemical and helmet stocks pay dividends?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, all three companies pay dividends. The dividend yield is 0.22% for Poly Medicure, 1.28% for Grauer & Weil and 0.72% for Studds, based on dividends declared for FY26.\"}},{\"@type\":\"Question\",\"name\":\"How can I invest in medical device, surface chemical and helmet stocks in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can buy medical device, surface chemical and helmet stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Poly Medicure, Grauer &#038; Weil (India) and Studds Accessories compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.<\/p>\n","protected":false},"author":28,"featured_media":316819,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[13393,7537,11166,13394,13395],"class_list":["post-316820","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-medical-device","tag-poly-medicure","tag-studds-accessories","tag-surface-chemical-and-helmet-stocks","tag-surface-chemical-and-helmet-stocks-to-buy"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["316819"],"rank_math_title":["Medical Device, Surface Chemical and Helmet Stocks"],"rank_math_description":["Medical device, surface chemical and helmet stocks with a strong roadmap: Poly Medicure, Grauer &amp; Weil and Studds compared on growth, valuation and risks."],"rank_math_focus_keyword":["medical device, surface chemical and helmet stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/3-medical-device-surface-chemical-and-helmet-stocks-with-a-strong-future-roadmap.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/316820","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=316820"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/316820\/revisions"}],"predecessor-version":[{"id":316821,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/316820\/revisions\/316821"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/316819"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=316820"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=316820"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=316820"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}